Daily Journal Staff Writer
When Allergan Inc. spun off its medical device business in 2001, Latham & Watkins LLP partner Cary K. Hyden and his team were there to guide the rare and complicated transaction.
The deal was Hyden's debut as outside counsel for Allergan and its "largest and most complex transaction to date," said Hyden, a corporate partner in Latham's Costa Mesa office. It would also lead...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In